Fact, not fiction: Why the American public needs to better understand genetic sequencing
Distrust in genetic sequencing and medical testing abound, but the fact is that genomic medicine is a breakthrough tool for diagnosis and treatment.
Amir Trabelsi
Amir Trabelsi is co-founder and CEO of Genoox, where he leads the company's vision, strategy, and growth. He strongly believes in building products that provide small teams with great power and is always looking for creative solutions to challenge the status quo. Founded in 2014, Genoox is a healthcare and technology company on a mission to make genetic sequencing more accessible. Prior to Genoox, Amir served as head of product development and strategy for Safend (acquired by Wave Systems), a data security company. Amir served in the elite technology intelligence unit for the Israel Defense Forces (IDF) and graduated from The Open University Of Israel with a B.Sc degree in Computer Science.